Volatility to be restrained with US tariffs in line with expectations
Expecting limited volatility as US resumes reciprocal tariffs.
Group Research - Econs, Chang Wei Liang1 Aug 2025
Article image
Photo credit: Unsplash/Adobe Stock Photo
Read More

The White House has confirmed that reciprocal tariffs will resume, though this is not a surprise to markets and should not trigger excessive market volatility as in April. Much of US trade has already been covered by the rash of trade deals announced previously. In fact, the USD has been building on its gains as tariff uncertainty dissipates, with the DXY rebounding back to 100. What is perhaps much less clear is the impact on US longer-term growth prospects due to tariffs, especially as the rest of the world continues to integrate with more trade.

MYR and THB should see a relief rebound, with US tariffs being set lower than their April 2 levels. Malaysia, Thailand, Cambodia will receive the same 19% tariff rate as Indonesia and the Philippines, which had already struck trade deals with the US. Vietnam’s 20% tariff remains unchanged. In North Asia, Taiwan will face a 20% tariff, compared to 15% for Korea and Japan that have negotiated US investment deals and are also US military allies. The minimum tariff rate remains at 10% for countries that were not named by the White House, including Singapore.

ASEAN’s similar tariff rates mean that countries’ relative investment competitiveness will not be distorted, and that ASEAN currencies as a group will not see significant divergence. US investment into this region should also broadly continue as cost advantages are significant. Still, export-oriented manufacturing investment will be less compelling than before for companies specifically targeting the US market, and there could also be a tightening of transhipment rules given US scrutiny and the threat of receiving a less favourable US tariff rate.

Across G10, the most notable hit is Switzerland, which received a 39% tariff rate—one of the highest tariff rates announced, and even higher than the Apr 2 level of 31%. USD/CHF has bumped up to mid-0.81 level in reaction, and CHF could face selling pressure given risks to Swiss exports to the US, dominated by pharmaceuticals. US-Swiss trade negotiations are still ongoing though, and markets may be careful to watch headlines over a possible deal to lower tariffs.

JPY has also depreciated against the USD, though less so compared to the EUR. BOJ keeping policy rates unchanged yesterday, with Governor Ueda pinning the rise of inflation on supply factors rather than demand, have tempered rate hike expectations and bumped USD/JPY above 150.

Chang Wei Liang

FX & Credit Strategist
[email protected]




Quote of the Day
“There are two ways of spreading light: to be the candle or the mirror that reflects it.”
     Edith Wharton

August 1 in history
In 1774, English chemist Joseph Priestley discovered oxygen by isolating it in its gaseous state.

 



 
Subscribe here to receive our economics & macro strategy materials.
To unsubscribe, please click here.
GENERAL DISCLOSURE/ DISCLAIMER (For Macroeconomics, Currencies, Interest Rates)

GENERAL DISCLOSURE/ DISCLAIMER (For Macroeconomics, Currencies, Interest Rates)

The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation.  Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies.  The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation.  The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.

[#for Distribution in Singapore] This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, DBS Bank Ltd accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.

DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E.

DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability. 18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.

DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability.  11th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.

Virtual currencies are highly speculative digital "virtual commodities", and are not currencies. It is not a financial product approved by the Taiwan Financial Supervisory Commission, and the safeguards of the existing investor protection regime does not apply.  The prices of virtual currencies may fluctuate greatly, and the investment risk is high. Before engaging in such transactions, the investor should carefully assess the risks, and seek its own independent advice.